Back to Search
Start Over
Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming
- Source :
- Journal of Internal Medicine
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
- Subjects :
- 2019-20 coronavirus outbreak
IgM
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
IgG
Denmark
Health Personnel
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serology
Priming (immunology)
Antibodies, Viral
SARS‐CoV‐2
RBD
Serology
Immunogenicity, Vaccine
COVID‐19
vaccine
antibody neutralization
Research Letter
Internal Medicine
Humans
Medicine
RNA, Messenger
BNT162 Vaccine
biology
SARS-CoV-2
business.industry
COVID-19
antibody response
Antibodies, Neutralizing
Virology
immunoassays
Antibody response
Immunoglobulin G
Antibody Formation
biology.protein
BNT162b2
Antibody
business
IgA
nucleocapsid protein
Subjects
Details
- ISSN :
- 13652796 and 09546820
- Volume :
- 290
- Database :
- OpenAIRE
- Journal :
- Journal of Internal Medicine
- Accession number :
- edsair.doi.dedup.....ec6bc598cb328d0951f45f5156d1b69d
- Full Text :
- https://doi.org/10.1111/joim.13366